The newly discovered membrane estrogen receptor GPR30, expressed in ~80% of endometrioid tumors (5), is a specific receptor for 17β-estradiol involved in the non-genomic effect of estrogen. The gene discussed is GPER1; the disease is endometrioid tumor.